A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening steatohepatitis.

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE phase 3 clinical trial published today in the New England Journal of ...

A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...